Chronic lymphocytic leukemia (CLL) can qualify for Social Security disability benefits, but approval depends on your diagnosis documentation, disease stage, and how the condition limits your ability to work. CLL is specifically listed in the Social Security Administration’s Blue Book under Section 13.06, which means it’s a recognized qualifying condition. That said, having a CLL diagnosis alone doesn’t guarantee approval. The SSA evaluates your case based on specific medical criteria and functional limitations.
How the SSA Evaluates CLL
The SSA lists CLL under Section 13.06c of its Blue Book, the manual used to determine which medical conditions qualify for disability. To meet this listing, your diagnosis must be supported by bloodwork showing a chronic lymphocyte count of at least 10,000 per cubic millimeter sustained for three months or longer, or by other diagnostic methods consistent with current medical practice (such as flow cytometry or bone marrow biopsy results).
Meeting the diagnostic threshold is only the first step. The SSA then evaluates the complications and residual effects of your CLL under related listings. Two pathways matter most here. The first is Section 13.05A2, which covers indolent (slow-growing) lymphomas. If your CLL has required you to start more than one course of cancer treatment within a 12-month period, you can be considered disabled from the date the failed treatment began. The second pathway uses the hematological (blood disorder) listings under Section 7.00, which cover complications like severe anemia or dangerously low platelet counts.
When CLL Is More Likely to Qualify
Your disease stage plays a significant role. CLL is classified using the Rai staging system, which ranges from stage 0 (low risk) to stage IV (high risk). Stages III and IV, where patients develop anemia or low platelet counts due to bone marrow failure, are considered high risk. Median survival in these stages has historically been around 19 months from diagnosis, and the disease typically progresses rapidly. By contrast, stage 0 patients have a median survival of about 150 months and may not need treatment for years.
This matters because early-stage CLL patients who are in a “watch and wait” phase, with no symptoms and no treatment, face a harder path to approval. The SSA is looking for evidence that your condition actually prevents you from working, not just that you carry the diagnosis. If your CLL is stage 0 or stage I with stable blood counts and no symptoms, an initial application is more likely to be denied.
Applications are strongest when you can document one or more of the following:
- Advanced disease stage with anemia (hemoglobin below 10 g/dL) or low platelets (below 100,000)
- Multiple rounds of treatment within 12 months that failed to control the disease
- Transformation to aggressive lymphoma (Richter syndrome), which qualifies for the SSA’s Compassionate Allowances program and receives expedited processing
- Persistent or recurrent disease after initial cancer treatment
Qualifying Without Meeting the Listing Exactly
Even if your CLL doesn’t meet the exact Blue Book criteria, you can still qualify through what the SSA calls a residual functional capacity (RFC) assessment. This is where the SSA looks at how your symptoms and treatment side effects limit what you can physically and mentally do in a work setting.
CLL often causes debilitating fatigue, frequent infections due to a weakened immune system, night sweats, and enlarged lymph nodes that cause pain or discomfort. Chemotherapy and targeted therapies add their own layer of side effects: nausea, cognitive difficulties, increased infection risk, and prolonged recovery periods. If these symptoms, taken together, prevent you from reliably performing even sedentary work, the SSA can approve your claim based on functional limitations rather than the listing criteria alone.
For an RFC-based claim, detailed documentation from your oncologist or hematologist is critical. The SSA needs records showing not just your diagnosis but how your symptoms affect daily activities: how often you miss appointments due to illness, how long you can sit or stand, whether fatigue prevents you from concentrating for a full workday, and how frequently infections keep you homebound.
What to Expect From the Process
Initial disability decisions typically take six to eight months. If your CLL has transformed into Richter syndrome (an aggressive large-cell lymphoma), your case qualifies for Compassionate Allowances, which fast-tracks the decision to weeks rather than months. Standard CLL without transformation goes through the normal timeline.
Denial rates on initial applications for all conditions are high, and many successful claimants are approved on appeal. If you’re applying with CLL, gather every piece of medical documentation before submitting: bloodwork history showing lymphocyte trends over time, pathology reports, treatment records including dates and types of therapy, and a detailed statement from your treating physician about your functional limitations. The more complete your file is at the initial application stage, the less likely you are to face a lengthy appeals process.
CLL and VA Disability Benefits
If you’re a veteran, CLL qualifies for disability compensation through the Department of Veterans Affairs under a separate process. The VA recognizes chronic B-cell leukemia (which includes CLL) as a condition linked to Agent Orange and other herbicide exposure. Veterans who served in areas where these chemicals were used, including Vietnam, Thailand, and certain test sites, can receive a presumptive service connection. This means you don’t need to prove the exposure directly caused your CLL; the VA presumes the connection based on your service history and diagnosis.
VA disability ratings for cancer are typically set at 100% during active treatment. After treatment ends, the VA schedules a re-evaluation and assigns a rating based on any residual effects, which can range from 0% to 100% depending on ongoing symptoms and complications. Because CLL is often managed rather than cured, many veterans maintain significant ratings long-term.